搜尋





搜尋





市場行情
/
股票
/
rlmd
/

Relmada Therapeutics Inc

RLMD

添加自選

5.310USD

0.0000.00%

收盤 07-31 16:00（美東）報價延遲15分鐘

556.97M總市值

虧損本益比TTM

Relmada Therapeutics Inc

5.310

0.0000.00%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

RLMD 利潤表

您可以在這裡找到Relmada Therapeutics Inc的年度或季度收入報告，以深入了解Relmada Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

FY2016Q2

FY2016Q1

FY2015Q4

FY2015Q3

FY2015Q2

FY2015Q1

FY2014Q4

FY2014Q1

FY2013Q4

FY2013Q3

FY2013Q2

FY2013Q1

FY2012Q4

FY2012Q3

FY2012Q2

FY2012Q1

營業總收入

----

--0.00

-100.00%0.00

58.50%634.00

-61.07%2.35K

--2.15K

--1.51K

--400.00

--6.03K

--0.00

營業收入

----

--0.00

-100.00%0.00

58.50%634.00

-61.07%2.35K

--2.15K

--1.51K

--400.00

--6.03K

--0.00

主營業務成本

----

-100.00%0.00

10.27%322.00

-58.66%1.86K

--1.85K

--998.00

--292.00

--4.51K

--0.00

營業費用

6.82%19.46M

6.59%20.33M

-55.12%10.33M

-45.69%10.22M

-20.75%18.22M

-28.90%19.08M

1.39%23.01M

-27.69%18.82M

-18.35%22.99M

-30.68%26.83M

-41.42%22.69M

-42.81%26.03M

-26.49%28.15M

13.22%38.70M

-9.18%38.74M

71.99%45.51M

70.93%38.30M

63.37%34.18M

148.22%42.65M

107.43%26.46M

124.63%22.41M

405.92%20.92M

535.96%17.18M

266.69%12.76M

313.67%9.97M

114.27%4.14M

5.96%2.70M

138.85%3.48M

145.83%2.41M

8.26%1.93M

11.69%2.55M

-5.19%1.46M

-39.33%980.86K

-42.53%1.78M

-16.90%2.28M

-73.15%1.54M

-65.08%1.62M

-29.87%3.10M

-39.86%2.75M

30.50%5.72M

24.37%4.63M

-63.84%4.42M

--4.57M

--4.38M

422.91%3.72M

98856.02%12.23M

6273.86%711.90K

21.88%12.36K

598.33%20.12K

5.53%6.49K

2444.19%11.17K

--10.14K

--2.88K

--6.15K

--439.00

研發費用

-32.33%8.09M

-26.61%8.07M

-63.80%4.04M

-73.70%2.82M

-10.18%11.95M

-25.43%11.00M

6.65%11.15M

-21.97%10.72M

-16.11%13.31M

-45.10%14.75M

-65.76%10.45M

-55.55%13.74M

-36.59%15.86M

6.31%26.87M

-10.19%30.53M

78.36%30.91M

78.38%25.01M

69.58%25.27M

202.51%33.99M

225.54%17.33M

211.07%14.02M

385.48%14.90M

780.69%11.24M

323.40%5.32M

217.12%4.51M

220.03%3.07M

-23.45%1.28M

734.27%1.26M

757.61%1.42M

419.78%959.25K

239.71%1.67M

-40.69%150.72K

-54.48%165.75K

-69.93%184.55K

-19.44%490.69K

-88.00%254.11K

-87.29%364.15K

-78.58%613.75K

-73.22%609.12K

1.27%2.12M

298.57%2.87M

358.97%2.86M

--2.27M

--2.09M

233.18%718.97K

--624.17K

--215.79K

----

折舊攤銷及損耗

----

--0.00

-100.00%0.00

-56.07%452.00

-22.94%806.00

-24.36%823.00

-20.56%854.00

-20.97%1.03K

-25.55%1.05K

17.12%1.09K

89.26%1.07K

123.71%1.30K

156.39%1.41K

-94.91%929.00

-97.56%568.00

-97.53%582.00

-97.28%548.00

-14.44%18.26K

-15.60%23.27K

698.00%23.58K

582.80%20.16K

545.33%21.34K

1026.23%27.57K

--2.96K

-17.84%2.95K

45.04%3.31K

--2.45K

----

7088.00%3.59K

1420.00%2.28K

--50.00

--150.00

--100.00

----

營業利潤

-6.82%-19.46M

-6.59%-20.33M

55.12%-10.33M

45.69%-10.22M

20.75%-18.22M

28.90%-19.08M

-1.39%-23.01M

27.69%-18.82M

18.35%-22.99M

30.68%-26.83M

41.42%-22.69M

42.81%-26.03M

26.49%-28.15M

-13.22%-38.70M

9.18%-38.74M

-71.99%-45.51M

-70.93%-38.30M

-63.37%-34.18M

-148.22%-42.65M

-107.43%-26.46M

-124.63%-22.41M

-405.92%-20.92M

-535.96%-17.18M

-266.69%-12.76M

-313.67%-9.97M

-114.27%-4.14M

-5.96%-2.70M

-138.85%-3.48M

-145.83%-2.41M

-8.26%-1.93M

-11.69%-2.55M

5.19%-1.46M

39.33%-980.86K

42.53%-1.78M

16.90%-2.28M

73.15%-1.54M

65.08%-1.62M

29.87%-3.10M

39.86%-2.75M

-30.50%-5.72M

-24.37%-4.63M

63.84%-4.42M

---4.57M

---4.38M

-422.91%-3.72M

-98856.02%-12.23M

-7792.42%-711.90K

-43.28%-12.36K

-685.37%-19.48K

-3190.48%-4.15K

-1954.67%-9.02K

---8.63K

---2.48K

---126.00

---439.00

淨非營業利息收入（費用）

利息收入

117.99%959.76K

-40.85%387.23K

-71.16%247.01K

-66.62%321.46K

-58.30%440.29K

-48.01%654.64K

-35.19%856.48K

-29.37%963.01K

-12.57%1.06M

12.98%1.26M

59.67%1.32M

252.00%1.36M

266.01%1.21M

602.52%1.11M

178.05%827.61K

19.99%387.33K

-21.44%329.95K

--158.65K

--297.65K

--322.81K

--419.97K

----

-83.49%843.00

-50.68%1.04K

-12.62%1.23K

--2.43K

--5.11K

--2.12K

--1.41K

--0.00

----

利息費用

----

6.74%1.17K

-49.76%1.64K

-99.86%431.00

--125.00

--1.10K

-97.36%3.27K

--311.81K

--123.80K

----

出售證券收益

-115.67%-9.87K

-364.23%-107.92K

-155.09%-81.44K

-64.54%47.20K

24.13%62.95K

101.22%40.84K

385.87%147.84K

--133.11K

107.61%50.71K

-9932.59%-3.35M

90.79%-51.71K

-100.00%0.00

-4338.21%-666.71K

72.82%-33.35K

-66.69%-561.65K

119.83%24.50K

71.54%-15.02K

-238.22%-122.68K

-291.02%-336.95K

-1064.79%-123.59K

69.24%-52.79K

--88.76K

---86.17K

--12.81K

---171.61K

----

特殊收入（費用）

-446.81%-540.10K

167.15%186.04K

-74.77%70.28K

69.65%-13.80K

193.10%155.73K

-107.39%-277.07K

148.10%278.56K

92.89%-45.47K

-95.88%53.13K

1260.84%3.75M

38.88%-579.15K

46.08%-639.63K

173.22%1.29M

-39.47%-323.12K

-1192.30%-947.51K

-310.10%-1.19M

-895.29%-1.76M

-52.72%-231.68K

2098.30%86.75K

-123.67%-289.28K

81.05%-177.16K

---151.71K

--3.95K

134.81%1.22M

-193.50%-934.92K

100.00%0.00

-1129.17%-3.51M

-5486.48%-318.54K

-484.77%-789.44K

-204.42%-254.86K

-24.04%341.11K

92.88%-5.70K

173.69%205.17K

-70.66%244.07K

-86.23%449.04K

-100.86%-80.04K

-102.66%-278.42K

-60.43%831.97K

-66.84%3.26M

135.59%9.29M

168.47%10.47M

--2.10M

--9.84M

-456.29%-26.11M

---15.28M

--7.33M

--0.00

100.00%0.00

--0.00

---377.00

--0.00

-固定資產出售收益

----

100.00%0.00

----

---96.40K

----

其他非經營性收入（費用）

----

--0.00

----

-100.00%0.00

----

--0.00

--6.35M

----

--0.00

-100.00%0.00

-95.87%2.35K

-34.60%40.29K

4.31%56.91K

--56.91K

--61.61K

--54.56K

----

稅前利潤

-8.50%-19.05M

-6.49%-19.87M

53.55%-10.09M

44.47%-9.87M

19.56%-17.56M

25.86%-18.66M

1.25%-21.73M

29.78%-17.77M

17.07%-21.83M

33.68%-25.17M

44.18%-22.00M

36.64%-25.30M

33.78%-26.32M

-10.37%-37.94M

7.48%-39.42M

-50.40%-39.93M

-78.91%-39.75M

-65.58%-34.38M

-152.07%-42.61M

-138.81%-26.55M

-108.14%-22.22M

-403.62%-20.76M

-529.27%-16.90M

-55.95%-11.12M

-215.77%-10.67M

-23.06%-4.12M

16.11%-2.69M

-399.48%-7.13M

-244.32%-3.38M

-105.06%-3.35M

-61.59%-3.20M

-38.47%-1.43M

40.16%-981.69K

50.76%-1.63M

-6.54%-1.98M

58.11%-1.03M

-135.18%-1.64M

-154.90%-3.32M

24.49%-1.86M

-145.11%-2.46M

115.63%4.66M

121.71%6.04M

---2.46M

--5.46M

-559.49%-29.84M

-224987.50%-27.83M

72093.68%6.49M

-43.28%-12.36K

-685.37%-19.48K

-724.25%-4.15K

-1954.67%-9.02K

---8.63K

---2.48K

---503.00

---439.00

所得稅

----

--4.42K

----

--0.00

----

--0.00

----

--0.00

除稅後利潤

-8.50%-19.05M

-6.49%-19.87M

53.55%-10.09M

44.47%-9.87M

19.56%-17.56M

25.86%-18.66M

1.25%-21.73M

29.78%-17.77M

17.07%-21.83M

33.68%-25.17M

44.18%-22.00M

36.64%-25.30M

33.78%-26.32M

-10.37%-37.94M

7.48%-39.42M

-50.40%-39.93M

-78.91%-39.75M

-65.58%-34.38M

-152.07%-42.61M

-138.81%-26.55M

-108.14%-22.22M

-403.62%-20.76M

-529.27%-16.90M

-55.95%-11.12M

-215.77%-10.67M

-23.06%-4.12M

16.11%-2.69M

-399.48%-7.13M

-244.32%-3.38M

-105.06%-3.35M

-61.59%-3.20M

-38.47%-1.43M

40.16%-981.69K

50.76%-1.63M

-6.54%-1.98M

58.11%-1.03M

-135.18%-1.64M

-154.90%-3.32M

24.49%-1.86M

-145.11%-2.46M

115.63%4.66M

121.71%6.04M

---2.46M

--5.46M

-559.49%-29.84M

-224987.50%-27.83M

72093.68%6.49M

-43.28%-12.36K

-685.37%-19.48K

-724.25%-4.15K

-1954.67%-9.02K

---8.63K

---2.48K

---503.00

---439.00

持續經營利潤

-8.50%-19.05M

-6.49%-19.87M

53.55%-10.09M

44.47%-9.87M

19.56%-17.56M

25.86%-18.66M

1.25%-21.73M

29.78%-17.77M

17.07%-21.83M

33.68%-25.17M

44.18%-22.00M

36.64%-25.30M

33.78%-26.32M

-10.37%-37.94M

7.48%-39.42M

-50.40%-39.93M

-78.91%-39.75M

-65.58%-34.38M

-152.07%-42.61M

-138.81%-26.55M

-108.14%-22.22M

-403.62%-20.76M

-529.27%-16.90M

-55.95%-11.12M

-215.77%-10.67M

-23.06%-4.12M

16.11%-2.69M

-399.48%-7.13M

-244.32%-3.38M

-105.06%-3.35M

-61.59%-3.20M

-38.47%-1.43M

40.16%-981.69K

50.76%-1.63M

-6.54%-1.98M

58.11%-1.03M

-135.18%-1.64M

-154.90%-3.32M

24.49%-1.86M

-145.11%-2.46M

115.63%4.66M

121.71%6.04M

---2.46M

--5.46M

-559.49%-29.84M

-224987.50%-27.83M

72093.68%6.49M

-43.28%-12.36K

-685.37%-19.48K

-724.25%-4.15K

-1954.67%-9.02K

---8.63K

---2.48K

---503.00

---439.00

反常淨利潤

----

--0.00

----

歸属于母公司的淨利潤

-8.50%-19.05M

-6.49%-19.87M

53.55%-10.09M

44.47%-9.87M

19.56%-17.56M

25.86%-18.66M

1.25%-21.73M

29.78%-17.77M

17.07%-21.83M

33.68%-25.17M

44.18%-22.00M

36.64%-25.30M

33.78%-26.32M

-10.37%-37.94M

7.48%-39.42M

-50.40%-39.93M

-78.91%-39.75M

-65.58%-34.38M

-152.07%-42.61M

-138.81%-26.55M

-108.14%-22.22M

-403.62%-20.76M

-529.27%-16.90M

-55.95%-11.12M

-215.77%-10.67M

-23.06%-4.12M

16.11%-2.69M

-399.48%-7.13M

-244.32%-3.38M

-105.06%-3.35M

-61.59%-3.20M

-38.47%-1.43M

40.16%-981.69K

50.76%-1.63M

-6.54%-1.98M

58.11%-1.03M

-135.18%-1.64M

-154.90%-3.32M

24.49%-1.86M

-145.11%-2.46M

115.63%4.66M

121.71%6.04M

---2.46M

--5.46M

-559.49%-29.84M

-224987.50%-27.83M

72093.68%6.49M

-43.28%-12.36K

-685.37%-19.48K

-724.25%-4.15K

-1954.67%-9.02K

---8.63K

---2.48K

---503.00

---439.00

歸屬普通股東的淨利潤

-8.50%-19.05M

-6.49%-19.87M

53.55%-10.09M

44.47%-9.87M

19.56%-17.56M

25.86%-18.66M

1.25%-21.73M

29.78%-17.77M

17.07%-21.83M

33.68%-25.17M

44.18%-22.00M

36.64%-25.30M

33.78%-26.32M

-10.37%-37.94M

7.48%-39.42M

-50.40%-39.93M

-78.91%-39.75M

-65.58%-34.38M

-152.07%-42.61M

-138.81%-26.55M

-108.14%-22.22M

-403.62%-20.76M

-529.27%-16.90M

-55.95%-11.12M

-215.77%-10.67M

-23.06%-4.12M

16.11%-2.69M

-399.48%-7.13M

-244.32%-3.38M

-105.06%-3.35M

-61.59%-3.20M

-38.47%-1.43M

40.16%-981.69K

50.76%-1.63M

-6.54%-1.98M

58.11%-1.03M

-135.18%-1.64M

-154.90%-3.32M

24.49%-1.86M

-145.11%-2.46M

115.63%4.66M

121.71%6.04M

---2.46M

--5.46M

-559.49%-29.84M

-224987.50%-27.83M

72093.68%6.49M

-43.28%-12.36K

-685.37%-19.48K

-724.25%-4.15K

-1954.67%-9.02K

---8.63K

---2.48K

---503.00

---439.00

基本每股收益

61.90%-0.22

47.41%-0.33

57.77%-0.30

49.52%-0.30

20.29%-0.58

26.05%-0.62

1.50%-0.72

29.95%-0.59

17.16%-0.72

33.67%-0.84

44.25%-0.73

36.98%-0.84

37.53%-0.87

29.99%-1.26

46.21%-1.31

14.31%-1.33

-4.43%-1.40

-41.03%-1.80

-131.39%-2.44

-114.56%-1.56

-85.10%-1.34

-155.28%-1.28

-194.53%-1.05

34.90%-0.73

32.78%-0.72

53.15%-0.50

64.96%-0.36

-144.95%-1.11

-243.84%-1.08

-99.13%-1.07

-55.00%-1.02

-32.82%-0.46

42.54%-0.31

51.43%-0.54

-6.26%-0.66

60.25%-0.34

-131.58%-0.55

-149.10%-1.10

32.45%-0.62

-140.09%-0.86

111.78%1.73

104.98%2.25

---0.92

--2.15

-662.23%-14.65

-490478.26%-45.13

34392.11%2.61

13.21%-0.01

-361.11%-0.02

-350.00%0.00

-1166.67%-0.01

---0.01

--0.00

稀釋每股收益

61.90%-0.22

47.41%-0.33

57.77%-0.30

49.52%-0.30

20.29%-0.58

26.05%-0.62

1.50%-0.72

29.95%-0.59

17.16%-0.72

33.67%-0.84

44.25%-0.73

36.98%-0.84

37.53%-0.87

29.99%-1.26

46.21%-1.31

14.31%-1.33

-4.43%-1.40

-41.03%-1.80

-131.39%-2.44

-114.56%-1.56

-85.10%-1.34

-155.28%-1.28

-194.53%-1.05

34.90%-0.73

32.78%-0.72

53.15%-0.50

64.96%-0.36

-144.95%-1.11

-243.84%-1.08

-99.13%-1.07

-55.00%-1.02

-32.82%-0.46

42.54%-0.31

51.43%-0.54

-6.26%-0.66

60.25%-0.34

-137.82%-0.55

-149.10%-1.10

32.45%-0.62

-155.64%-0.86

109.84%1.44

104.98%2.25

---0.92

--1.55

-662.23%-14.65

-490478.26%-45.13

34392.11%2.61

13.21%-0.01

-361.11%-0.02

-350.00%0.00

-1166.67%-0.01

---0.01

--0.00

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Relmada Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 RLMD 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Relmada Therapeutics Inc 全年的淨利潤是多少？



Relmada Therapeutics Inc 2025 財年淨利潤為 -57.39M。

Relmada Therapeutics Inc 上一季度的淨利潤是多少？



Relmada Therapeutics Inc 最近一個季度的淨利潤為 -19.05M。

Relmada Therapeutics Inc 年度營業利潤是多少？



Relmada Therapeutics Inc 2025 財年的營業利潤為 -59.10M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。